心脑血管疾病对类风湿关节炎患者痴呆风险的影响:一项中介分析
这项回顾性人群研究纳入1754例50岁以上新发类风湿关节炎患者及1:1匹配的无类风湿关节炎对照,随访期间分别有105例和102例发生阿尔茨海默病及相关痴呆,444例和375例发生心血管疾病;类风湿关节炎与痴呆的关联未达统计学显著(aHR 1.27,95%CI 0.96,1.69),心血管疾病的中介效应不显著(p=0.84),但两者对痴呆风险存在显著交互作用(aHR 1.95,95%CI 1.11,3.42;p=0.021)。
要点
- 类风湿关节炎与阿尔茨海默病及相关痴呆的关联未达统计学显著(aHR 1.27,95%CI 0.96,1.69)。
- 心血管疾病对类风湿关节炎患者痴呆风险的中介效应不显著(p=0.84)。
- 类风湿关节炎与心血管疾病对痴呆风险存在显著交互作用(aHR 1.95,95%CI 1.11,3.42;p=0.021)。
核心结论
- 类风湿关节炎患者的阿尔茨海默病及相关痴呆风险似乎在合并心血管疾病时升高,心血管疾病并非显著中介因素,两者对痴呆风险存在显著协同效应。
研究设计与样本
- 回顾性人群研究,纳入1980-2014年符合1987年美国风湿病学会(ACR)标准、50岁以上的新发类风湿关节炎患者,按年龄、性别和索引年份1:1匹配无类风湿关节炎对照,心血管疾病事件从电子健康记录中人工提取,采用Cox比例风险模型和时间依赖性中介分析。
主要发现
- 共纳入1754人(877例类风湿关节炎患者和877例无类风湿关节炎对照)。
- 随访期间,105例类风湿关节炎患者和102例无类风湿关节炎对照发生阿尔茨海默病及相关痴呆,444例类风湿关节炎患者和375例无类风湿关节炎对照发生心血管疾病。
- 类风湿关节炎与阿尔茨海默病及相关痴呆的关联在不将心血管疾病作为时间依赖性中介因素时未达统计学显著(aHR 1.27,95%CI 0.96,1.69),将其作为时间依赖性中介因素时亦未达统计学显著(aHR 1.27,95%CI 0.95,1.68)。
- 任何心血管疾病对阿尔茨海默病及相关痴呆风险的中介效应不显著(p=0.84)。
- 类风湿关节炎与心血管疾病对阿尔茨海默病及相关痴呆风险存在显著交互作用(aHR 1.95,95%CI 1.11,3.42;p=0.021)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine the role of cardiovascular disease (CVD) as a mediator in the pathway between rheumatoid arthritis (RA) and Alzheimer's disease and related dementias (ADRD). METHODS: This retrospective population-based study included patients over 50 years of age with incident RA, who met the 1987 ACR criteria in 1980-2014. This cohort was matched 1:1 on age, sex and index year to comparators without RA. Information on CVD events was manually extracted from electronic health records. The relationships between RA, CVD and ADRD were examined using Cox proportional hazard models. Time dependent mediation analysis was used to examine the role of CVD as a mediator between RA and ADRD. RESULTS: 1754 individuals were included (877 persons with RA and 877 comparators without RA). During follow-up, 105 patients with RA and 102 individuals without RA developed ADRD; 444 patients with RA and 375 individuals without RA developed CVD. There was a non-significant association between RA and ADRD both without (aHR 1.27, 95 % CI 0.96, 1.69) and with (aHR 1.27, 95 % CI 0.95,1.68) CVD as a time dependent mediator. The mediation effect of any CVD on ADRD risk was not significant (p = 0.84). We found a significant interaction between RA and CVD on the risk of ADRD (aHR 1.95, 95 % CI 1.11, 3.42; p = 0.021). CONCLUSIONS: The risk of ADRD in RA appears to be increased mainly in the presence of CVD. CVD was not a significant mediator on the risk of ADRD in RA. There was a significant synergistic effect of RA and CVD on ADRD risk.
引用
- Lovering E, Kodishala C, George RJ, et al. The impact of cardiovascular and cerebrovascular disease on the risk of dementia in rheumatoid arthritis: A mediation analysis. Semin Arthritis Rheum. 2024. PMID: 39413451. doi:10.1016/j.semarthrit.2024.152570
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。